Meyka Pro banner
The Clorox Company

The Clorox Company Fundamental Analysis (NYSE: CLX)

CLXNYSE
Consumer DefensiveHousehold & Personal Products
$89.31
$1.55(1.77%)
U.S. Market opens in 14h 44m

The Clorox Company Fundamental Analysis (NYSE: CLX)

The Clorox Company (NYSE: CLX) shows weak financial fundamentals with a PE ratio of 18.16, profit margin of 8.74%, and ROE of -18.94%. The company generates $6.7B in annual revenue with weak year-over-year growth of 0.16%.

Key Strengths

Operating Margin24.73%
PEG Ratio-0.68

Areas of Concern

ROE-18.94%
Cash Position1.31%
Current Ratio0.66
We analyze CLX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -1878.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-1878.6/100

We analyze CLX's fundamental strength across five key dimensions:

Efficiency Score

Weak

CLX struggles to generate sufficient returns from assets.

ROA > 10%
7.53%

Valuation Score

Excellent

CLX trades at attractive valuation levels.

PE < 25
18.16
PEG Ratio < 2
-0.68

Growth Score

Weak

CLX faces weak or negative growth trends.

Revenue Growth > 5%
0.16%
EPS Growth > 10%
1.92%

Financial Health Score

Weak

CLX carries high financial risk with limited liquidity.

Debt/Equity < 1
61.33
Current Ratio > 1
0.66

Profitability Score

Weak

CLX struggles to sustain strong margins.

ROE > 15%
-1893.55%
Net Margin ≥ 15%
8.74%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is CLX Expensive or Cheap?

P/E Ratio

CLX trades at 18.16 times earnings. This indicates a fair valuation.

18.16

PEG Ratio

When adjusting for growth, CLX's PEG of -0.68 indicates potential undervaluation.

-0.68

Price to Book

The market values The Clorox Company at 118.45 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

118.45

EV/EBITDA

Enterprise value stands at 5.66 times EBITDA. This is generally considered low.

5.66

How Well Does CLX Make Money?

Net Profit Margin

For every $100 in sales, The Clorox Company keeps $8.74 as profit after all expenses.

8.74%

Operating Margin

Core operations generate 24.73 in profit for every $100 in revenue, before interest and taxes.

24.73%

ROE

Management delivers $-18.94 in profit for every $100 of shareholder equity.

-18.94%

ROA

The Clorox Company generates $7.53 in profit for every $100 in assets, demonstrating efficient asset deployment.

7.53%

Following the Money - Real Cash Generation

Operating Cash Flow

The Clorox Company generates limited operating cash flow of $607.71M, signaling weaker underlying cash strength.

$607.71M

Free Cash Flow

The Clorox Company produces free cash flow of $402.16M, offering steady but limited capital for shareholder returns and expansion.

$402.16M

FCF Per Share

Each share generates $3.33 in free cash annually.

$3.33

FCF Yield

CLX converts 3.82% of its market value into free cash.

3.82%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

18.16

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.68

vs 25 benchmark

P/B Ratio

Price to book value ratio

118.45

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.58

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

61.33

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.66

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-18.94

vs 25 benchmark

ROA

Return on assets percentage

0.08

vs 25 benchmark

ROCE

Return on capital employed

0.33

vs 25 benchmark

How CLX Stacks Against Its Sector Peers

MetricCLX ValueSector AveragePerformance
P/E Ratio18.1621.00 Better (Cheaper)
ROE-1893.55%628.00% Weak
Net Margin8.74%-2493.00% (disorted) Weak
Debt/Equity61.330.83 Weak (High Leverage)
Current Ratio0.662.25 Weak Liquidity
ROA7.53%299.00% Weak

CLX outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews The Clorox Company's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

7.67%

Industry Style: Defensive, Dividend, Low Volatility

Growing

EPS CAGR

-12.13%

Industry Style: Defensive, Dividend, Low Volatility

Declining

FCF CAGR

-35.36%

Industry Style: Defensive, Dividend, Low Volatility

Declining

Fundamental Analysis FAQ